Bibliography
- Carr A, Samaras K, Chisholm DJ, et al. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia, and insulin resistance. Lancet 1998; 131(9119):1881–3
- Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353(9170):2093–9
- Gervasoni C, Ridolfo A, Trifiro G, et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 1999; 13(4):465–71
- International Medical Press. First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV: rapid report. Available at: http://www.intmedpress.com/lipodystrophy/newinfo/RapidReport.htm. Accessed January 28, 2000
- Kotler DP. Summary report: First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Available at: http://www.medscape.com/Medscape/HIV/journal/1999/v05.n04. Accessed January 28, 2000
- Kotler DP. Update on metabolic and morphologic abnormalities in HIV. Medscape HIV/AIDS treatment updates Web site. Available at: http://HIV.medscape.com/Medscape/HIV/TreatmentUpdate/1999/tul1/public/toc-tull.html. Accessed January 28, 2000
- Saint-Marc T, Poizot-Martin I, Partisani M, et al. A syndrome of lipodystrophy in patients receiving a stable nucleoside-analogue therapy. (Abstr 653) Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999